Portfolio Review: Biogen & T. Rowe Price By: TalkMarkets September 12, 2021 at 22:16 PM EDT Biogen reported second quarter sales declined 25% to $2.8 billion. T. Rowe Price reported strong second quarter results with revenues rising 36% to $1.9 billion. Read More >> Related Stocks: Biogen Idec T.Rowe Price Group